View Author
trial myeloma patient sample bortezomib response expression blood therapy classi study survival genomic analysis signi gene expression figure erasmus mc table number phase accuracy tumor myeloma cells group classi fier research marrow prognostic j clin oncol survival classi fier gene expression data outcome treatment model protein probe sets signi ficantly dataset bortezomib trials blood myeloma purity score score speci subtype level factor disease millennium pharmaceuticals erasmu subset dex arm plasma 2012. cancer library prediction ficant purity control gene sets value volume april al blood analyses article bone marrow aspirate pathway information population probe american society translocation tc subtypes aspirate mulligan speci ficity signi ficance system pharmacogenomic
1 Most Recent Publications
|
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib
(Article)
Mulligan, G. Mitsiades, C. Trepicchio, W.L. Broyl, A. Sonneveld, P. Shaughnessy, J. Bergsagel, P.L. Schenkein, D. Esseltine, D-L. Boral, A.L. Anderson, K.C. Bryant, B. Zhan, F. Chng, W.J. Roels, S. Koenig, E. Fergus, A. Huang, Y. Richardson, P.G. |
2007-04-15
|